Elie Youssef Chakhtoura, MD - Medicare Cardiovascular Disease (cardiology) in West Orange, NJ

Elie Youssef Chakhtoura, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in West Orange, New Jersey. He graduated from medical school in 1991 and has 33 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Core Diagnostics Pa, Barnabas Health Medical Group Pc and his current practice location is 375 Mount Pleasant Ave, West Orange, New Jersey. You can reach out to his office (for appointments etc.) via phone at (973) 731-9442.

Elie Youssef Chakhtoura is licensed to practice in New Jersey (license number 25MA06177900) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1376543868.

Contact Information

Elie Youssef Chakhtoura, MD
375 Mount Pleasant Ave,
West Orange, NJ 07052-2724
(973) 731-9442
(973) 731-8030



Physician's Profile

Full NameElie Youssef Chakhtoura
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience33 Years
Location375 Mount Pleasant Ave, West Orange, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Elie Youssef Chakhtoura graduated from medical school in 1991
  NPI Data:
  • NPI Number: 1376543868
  • Provider Enumeration Date: 07/26/2005
  • Last Update Date: 09/22/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 2567459241
  • Enrollment ID: I20040426001552

Medical Identifiers

Medical identifiers for Elie Youssef Chakhtoura such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1376543868NPI-NPPES
0035858MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 25MA06177900 (New Jersey)Primary
207RI0011XInternal Medicine - Interventional Cardiology 25MA06177900 (New Jersey)Secondary
207UN0901XNuclear Medicine - Nuclear Cardiology 25MA06177900 (New Jersey)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Clara Maass Medical CenterBelleville, NJHospital
Saint Barnabas Medical CenterLivingston, NJHospital
Newark Beth Israel Medical CenterNewark, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Core Diagnostics Pa70129443254
Barnabas Health Medical Group Pc9537316955558

News Archive

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced that it has dosed the first patient in a Phase II trial for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Video games help brain to improve strategic thinking

Certain types of video games can help to train the brain to become more agile and improve strategic thinking, according to scientists from Queen Mary University of London and University College London (UCL).

Phytoestrogens linked with a lower lung cancer risk

A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the current issue of Journal of the American Medical Association (JAMA).

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.

Bloomberg examines Sec. of State Clinton's focus on women

Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Elie Youssef Chakhtoura allows following entities to bill medicare on his behalf.
Entity NameInternet Medical Group P C
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720044555
PECOS PAC ID: 2466357058
Enrollment ID: O20031205000536

News Archive

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced that it has dosed the first patient in a Phase II trial for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Video games help brain to improve strategic thinking

Certain types of video games can help to train the brain to become more agile and improve strategic thinking, according to scientists from Queen Mary University of London and University College London (UCL).

Phytoestrogens linked with a lower lung cancer risk

A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the current issue of Journal of the American Medical Association (JAMA).

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.

Bloomberg examines Sec. of State Clinton's focus on women

Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.

Read more Medical News

› Verified 5 days ago

Entity NameCore Diagnostics Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467573105
PECOS PAC ID: 7012944325
Enrollment ID: O20050803000044

News Archive

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced that it has dosed the first patient in a Phase II trial for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Video games help brain to improve strategic thinking

Certain types of video games can help to train the brain to become more agile and improve strategic thinking, according to scientists from Queen Mary University of London and University College London (UCL).

Phytoestrogens linked with a lower lung cancer risk

A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the current issue of Journal of the American Medical Association (JAMA).

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.

Bloomberg examines Sec. of State Clinton's focus on women

Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.

Read more Medical News

› Verified 5 days ago

Entity NameBarnabas Health Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841557246
PECOS PAC ID: 9537316955
Enrollment ID: O20120820000951

News Archive

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced that it has dosed the first patient in a Phase II trial for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Video games help brain to improve strategic thinking

Certain types of video games can help to train the brain to become more agile and improve strategic thinking, according to scientists from Queen Mary University of London and University College London (UCL).

Phytoestrogens linked with a lower lung cancer risk

A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the current issue of Journal of the American Medical Association (JAMA).

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.

Bloomberg examines Sec. of State Clinton's focus on women

Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elie Youssef Chakhtoura is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Elie Youssef Chakhtoura, MD
375 Mount Pleasant Ave,
West Orange, NJ 07052-2724

Ph: (973) 731-9442
Elie Youssef Chakhtoura, MD
375 Mount Pleasant Ave,
West Orange, NJ 07052-2724

Ph: (973) 731-9442

News Archive

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced that it has dosed the first patient in a Phase II trial for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

Video games help brain to improve strategic thinking

Certain types of video games can help to train the brain to become more agile and improve strategic thinking, according to scientists from Queen Mary University of London and University College London (UCL).

Phytoestrogens linked with a lower lung cancer risk

A diet higher in plant-derived compounds known as phytoestrogens is linked with a lower lung cancer risk, according to a study in the current issue of Journal of the American Medical Association (JAMA).

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.

Bloomberg examines Sec. of State Clinton's focus on women

Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.

Read more News

› Verified 5 days ago


Internal Medicine Doctors in West Orange, NJ

Dr. Lincoln Miller, MD
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 1500 Pleasant Valley Way, Suite 201, West Orange, NJ 07052
Phone: 973-966-6400    Fax: 973-514-1587
Dr. David P Dobesh, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 375 Mount Pleasant Ave, West Orange, NJ 07052
Phone: 973-731-9442    Fax: 973-731-2918
Dr. Iftekhar Kadri, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 372 Valley Rd, West Orange, NJ 07052
Phone: 973-736-2600    Fax: 973-736-8355
Dr. Natalie Johnson, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 470 Prospect Ave, Suite 200, West Orange, NJ 07052
Phone: 973-243-0290    Fax: 973-243-1863
Dr. Mahidhar Mahasamudram Reddy, MD
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 1199 Pleasant Valley Way, West Orange, NJ 07052
Phone: 973-830-7694    
Mark Goldberg, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 741 Northfield Ave, Ste 205, West Orange, NJ 07052
Phone: 973-467-1544    Fax: 973-467-9586
Dr. Audrey B Radin,
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 80 Main St Ste 300, West Orange, NJ 07052
Phone: 855-619-4448    Fax: 732-784-9918

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.